Adma Biologics Inc (ADMA)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 49.98M | 56.91M | 60.12M | 67.27M | 73.9M | 81.88M | 107.19M | 119.84M |
Operating Income | -6.06M | -813k | -474k | 8.69M | 14.23M | 21.82M | 39.2M | 39.64M |
Pre Tax Income | -12.23M | -6.79M | -6.37M | 2.57M | -17.65M | 18.4M | 35.85M | 36.75M |
Net Income | -12.23M | -6.79M | -6.37M | 2.57M | -17.65M | 17.81M | 32.06M | 35.91M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -6.5M | -840k | -487k | 8.54M | 14.13M | 21.79M | 39.19M | 39.58M |
EBITDA | -4.12M | 1.22M | 1.62M | 10.78M | 16.34M | 23.94M | 41.25M | 41.58M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.66M | 22.76M | 16.99M | 29.35M | 42.22M | 80.94M | 154.08M | 258.22M |
Operating Income | -17.33M | -38.47M | -60.29M | -41.43M | -64.91M | -58.37M | -39.37M | 21.63M |
Pre Tax Income | -19.52M | -43.76M | -65.75M | -48.28M | -75.75M | -71.65M | -65.9M | -28.24M |
Net Income | -19.52M | -43.76M | -65.75M | -48.28M | -75.75M | -71.65M | -65.9M | -28.24M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.649 | -0.7 | -1.035 | -0.631 | -0.62 | -0.336 | -0.276 | -0.116 |
EBIT | -17.33M | -38.48M | -60.42M | -30.13M | -65.04M | -58.63M | -40M | 21.35M |
EBITDA | -16.86M | -35.77M | -56.84M | -38.17M | -60.97M | -52.88M | -32.25M | 29.96M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.